[March 21, 2018]

Global Anticoagulants Strategic Business Report 2018: Focus on Oral Anticoagulants & Injectable Anticoagulants (Unfractionated Heparin, & Low Molecular Weight Heparin) - ResearchAndMarkets.com

The "Anticoagulants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Anticoagulants in US$ Million by the following Segments:

• Oral Anticoagulants
• Injectable Anticoagulants (Unfractionated Heparin, & Low Molecular Weight Heparin)

The report profiles 48 companies including many key and iche players such as:

• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bayer AG (Germany)
• Boehringer Ingelheim (Germany)
• Bristol-Myers Squibb Company (USA)
• Mitsubishi (News - Alert) Tanabe Pharma Corporation (Japan)
• Pfizer, Inc. (USA)
• Sanofi S.A. (France)
• Teva Pharmaceutical Industries Ltd. (Israel)

Key Topics Covered:

1. Global Market Overview

2. Market Trends & Issues

3. Segment Analysis

4. Therapeutic Indications

5. Product Introductions/Approvals

6. Recent Industry Activity

7. Focus On Select Global Players

8. Global Market Perspective

Total Companies Profiled: 48 (including Divisions

Subsidiaries - 58)

• The United States (23)
• Japan (3)
• Europe (30)
  • France (1)
  • Germany (4)
  • The United Kingdom (4)
  • Spain (1)
  • Rest of Europe (5)
• Asia-Pacific (Excluding Japan) (15)
• Africa (2)

For more information about this report visit https://www.researchandmarkets.com/research/zt4sg8/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180321005584/en/

[ Back To TMCnet.com's Homepage ]